Computed Tomography–Derived Radiomic Metrics Can Identify Responders to Immunotherapy in Ovarian Cancer

PURPOSE: To determine if radiomic measures of tumor heterogeneity derived from baseline contrast-enhanced computed tomography (CE-CT) are associated with durable clinical benefit and time to off-treatment in patients with recurrent ovarian cancer (OC) enrolled in prospective immunotherapeutic trials...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Precis Oncol
Main Authors: Himoto, Yuki, Veeraraghavan, Harini, Zheng, Junting, Zamarin, Dmitriy, Snyder, Alexandra, Capanu, Marinela, Nougaret, Stephanie, Vargas, Hebert A., Shitano, Fuki, Callahan, Margaret, Wang, Wei, Sala, Evis, Lakhman, Yulia
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
Original Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446503/
https://ncbi.nlm.nih.gov/pubmed/32914033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00038
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados